Forbes  Oct 7  Comment 
Walgreen, the leading drugstore chain with more than 8,210 locations across the U.S., lately has been transforming itself to realign its strategy to focus on its core retail pharmacy business.
TechCrunch  Jun 3  Comment 
Roughly 10 weeks after drugstore giant Walgreens announced its intention to acquire online retailer Drugstore.com for approximately $409 million, the company this morning said that it has completed the purchase. The transaction includes all...
Stock Blog Hub  Apr 7  Comment 
The law firm of Brower Piven has announced a class action lawsuit in connection with the proposed acquisition of drugstore.com by Walgreen (WAG), one of the largest retail pharmacy chains in the US. The lawsuit has been filed by all the...
Forbes  Apr 1  Comment 
The reviews have been primarily positive with most analysts and retail industry observers giving Walgreen the thumbs up for the deal it signed to acquire drugstore.com.
TheStreet.com  Mar 29  Comment 
="Scripts/swfobject_modified.js" type="text/javascript"> if !IE--> endif--> Content on this page requires a newer version of Adobe Flash Player. Click to view a price quote on AMZN. ...
Penny Stock DD  Mar 25  Comment 
Now these first stocks are wild card trades and I suggest that you wait for the open-15 minutes as these stocks may see profit taking on the opening bell.  LPTH [wikichart align="right" ticker="LPTH" showannotations="true" livequote="true"...
Wall Street Journal  Mar 24  Comment 
In the digital age, investors don't mind paying a premium for faster results. Or so it appeared Thursday.
New York Times  Mar 24  Comment 
The pharmacy chain Walgreen, focusing on retail drugs, expands its online exposure, while its rival CVS Caremark pursues the pharmacy benefit management business.
StreetInsider.com  Mar 24  Comment 
drugstore.com (Nasdaq: DSCM) 110.9% HIGHER; Walgreen Co. (NYSE: WAG) has entered into an agreement for the acquisition of drugstore.com in a deal with an enterprise value of $409 million. Under the terms of the merger agreement, drugstore.com...
Jutia Group  Mar 24  Comment 
As a group of Ford Motor (NYSE:F) managers in blue jeans sat down to interview a suit-wearing candidate from a California technology company this month, they jokingly offered to cut off his tie to put him at ease. Auto industry executives are...


[drugstore.com], Inc., (DSCM), is a leading provider of online health, beauty, wellness, personal care, vision, and pharmacy solutions. The company believes its online stores, including drugstore.com, beauty.com, and visiondirect.com, offer a better way for consumers to shop for these products. Customer loyalty is strong. Repeat customers represent approximately 82% of sales. The company operates primarily in the U.S. and Canada, but its products are available to consumers worldwide. Following the acquisition of International Vision Direct Corp. in November 2003, the company organized its operations into four segments: over-the-counter (OTC), mail-order and local pick-up pharmacy, and vision. In 2006, OTC accounted for 48% of net sales, pharmacy 40%, and vision 12%. The OTC segment offers non-prescription health, beauty, wellness, and personal care products. Many of the products found in specialty stores, such as Dr. Weil Recommends, GNC Live Well, and the Natural Store are also available through drugstore.com. The mail-order pharmacy segment delivers prescription drugs and supplies to customers. The company is a mail-order prescription provider for several pharmacy benefit management (PBM) companies and is working to expand this distribution channel. One attractive feature that drugstore.com offers is an innovative online tracking and substantiation system, which allows participating consumers to automatically track and submit expenses for products eligible for reimbursement under corporate flexible spending accounts without attaching receipts. Like Amazon, the PBM companies also provide marketing support. The local pick-up pharmacy segment offers prescriptions that can be picked up at Rite Aid stores. The vision segment offers prescription contact lenses and other vision products through Vision Direct.

We are reiterating our Buy rating and $4.50 target price on DSCM shares. We are positive on the stock, due to the company's improving profitability, Auto Delivery program, and strategic relationships. We expect these three factors to enable the company to deliver profitable growth in the years ahead.

While the company's sales growth was just 6.7% in the third quarter, we think investors should focus on what the company is doing to become profitable. For example, drugstore.com's third quarter contribution margin dollars improved by 18% thanks its gross margin expanding 170 basis points to 23.2%, which is the highest in the company's history. Moreover, the company again delivered positive EBITDA, which is defined as a non-GAAP financial measure of earnings before interest, taxes, depreciation, and amortization of intangible assets and non-cash marketing expense, adjusted to exclude the impact of stock-based compensation expense. What's more, we think that drugstore.com has set the stage to more than triple its adjusted EBITDA in 2007 and report break-even EPS in the fourth quarter of 2007. Another facet of the company's improvement comes from its stable customer base. This should enable the company's business model to generate stable revenue and cash flow thanks to the large percentage of repeat customer orders, which accounted for 82% of its third quarter sales. Part of this success comes from its Auto Delivery program, which provides automatic delivery for its repeat customers. This program was launched in the first quarter of 2006 with less than 100 products. The program is now available for approximately 2,000 products. The increase in available products was driven by customer demand, which is a clear positive. Lastly, drugstore.com has ended unprofitable relationships and negotiating more profitable deals with partners that it keeps. This is causing some near-term pressure on its sales growth. It is important to notes that the company is willing to endure slower sales growth but sales are still growing in the short term in order to improve its profit margins. All told, we are positive on the company's plan to become profitable. We believe the stock is a Buy and has the potential to reach $4.50 per share, which represents a price-to-sales ratio of 1.0x.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki